Affordable Access

Co-Administration of Injected and Oral Vaccine Candidates Elicits Improved Immune Responses over Either Route Alone

Authors
  • Hayden, Celine A.
  • Landrock, Danilo
  • Hung, Chiung Yu
  • Ostroff, Gary R.
  • Fake, Gina M.
  • Walker, John H.
  • Kier, Ann
  • Howard, John A.
Publication Date
Jan 21, 2020
Source
[email protected]
Keywords
License
Green
External links

Abstract

Infectious diseases continue to be a significant cause of morbidity and mortality, and although efficacious vaccines are available for many diseases, some parenteral vaccines elicit little or no mucosal antibodies which can be a significant problem since mucosal tissue is the point of entry for 90% of pathogens. In order to provide protection for both serum and mucosal areas, we have tested a combinatorial approach of both parenteral and oral administration of antigens for diseases caused by a viral pathogen, Hepatitis B, and a fungal pathogen, Coccidioides. We demonstrate that co-administration by the parenteral and oral routes is a useful tool to increase the overall immune response. This can include achieving an immune response in tissues that are not elicited when using only one route of administration, providing a higher level of response that can lead to fewer required doses or possibly providing a better response for individuals that are considered poor or non-responders.

Report this publication

Statistics

Seen <100 times